FDA Inspection
Rishi Kakar, M.D.Rishi Kakar, M.D. – FDA Inspection, Aug 9, 2021
Record Details
This FDA Inspection record concerns Rishi Kakar, M.D., with an inspection on August 9, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Rishi Kakar, M.D.
- Inspection Date
- August 9, 2021
- Product Type
- Drugs
View Company Profile
ID · cb941bec-9e6b-4f0f-91f4-6a714d436386
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1148264
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.60FD-1572, protocol compliance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Rishi Kakar, M.D.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| January 22, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| August 29, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| December 11, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Rishi Kakar, M.D.
- FDA Inspection 1227979 - 2024-01-22
- FDA Inspection 1102117 - 2019-08-29
- FDA Inspection 1078107 - 2018-12-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.